Stay updated on EPX-100 Add-on Control in Dravet Syndrome Clinical Trial
Sign up to get notified when there's something new on the EPX-100 Add-on Control in Dravet Syndrome Clinical Trial page.
Latest updates to the EPX-100 Add-on Control in Dravet Syndrome Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3, indicating a new release.SummaryDifference0.3%
- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.3%
- Check39 days agoChange DetectedA new study on EPX-100 (Clemizole Hydrochloride) for Dravet Syndrome has been added, while a previous study on its use as add-on therapy has been removed.SummaryDifference3%
- Check54 days agoChange DetectedThe website has been updated to version 2.10.0, introducing new features for viewing and comparing study record versions.SummaryDifference6%
- Check61 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.3%
- Check75 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the webpage.SummaryDifference0.3%
Stay in the know with updates to EPX-100 Add-on Control in Dravet Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EPX-100 Add-on Control in Dravet Syndrome Clinical Trial page.